logo

For the Inventor, By the Inventor

Plymouth, MN, United States of America

Phillip Edward McDonald

This inventor holds 16 USPTO granted patents and 1 EPO patent. Top assignees: Warsaw Orthopedic, Inc., Medtronic, Inc.. Active years: 2014-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Phillip Edward McDonald. Retrieved from https://idiyas.com/inventor/phillip-edward-mcdonald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16

% Patents Active = 93.8

 

Average Co-Inventor Count = 4.0

ph-index = 7

Forward Citations = 119(Granted Patents)


Location History:

  • Hibbing, MN (US) (2015)
  • Plymouth, MN (US) (2014 - 2017)

Company Filing History:

goldMedal12 out of 2,513 
 
Warsaw Orthopedic, Inc.
 patents
silverMedal5 out of 8,956 
 
Medtronic, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2014-2017

Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents
1. 9833548 - Methods and compositions for treating post-operative pain comprising clonidine (2017-12-05),
2. 9775882 - Medical devices and methods including polymers having biologically active agents therein (2017-10-03),
3. 9775800 - Compositions and methods for treating post-operative pain using clonidine and bupivacaine (2017-10-03),
4. 9770438 - Clonidine formulation in a polyorthoester carrier (2017-09-26),
5. 9763917 - Clonidine formulations in a biodegradable polymer carrier (2017-09-19),
6. 9585872 - Clonidine formulations in a biodegradable polymer carrier (2017-03-07),
7. 9549920 - Methods and compositions for treating post-operative pain comprising a local anesthetic (2017-01-24),
8. 9211285 - Methods and compositions for treating post-operative pain comprising clonidine (2015-12-15),
9. 9132119 - Clonidine formulation in a polyorthoester carrier (2015-09-15),
10. 9132085 - Compositions and methods for treating post-operative pain using clonidine and bupivacaine (2015-09-15),
11. 9005634 - Shelf stable pharmaceutical depot (2015-04-14),
12. 8999368 - Medical devices and methods including polymers having biologically active agents therein (2015-04-07),
13. 8946277 - Clonidine formulations in a biodegradable polymer carrier (2015-02-03),
14. 8846068 - Methods and compositions for treating post-operative pain comprising a local anesthetic (2014-09-30),
15. 8822546 - Flowable pharmaceutical depot (2014-09-02),

Title: The Innovations of Phillip Edward McDonald

Introduction

Phillip Edward McDonald is a notable inventor based in Plymouth, MN (US). He has made significant contributions to the field of pain management through his innovative inventions. With a total of 16 patents to his name, McDonald has focused on developing methods and compositions that enhance post-operative care.

Latest Patents

Among his latest patents is a method for treating post-operative pain using clonidine. This invention involves an implantable drug depot designed to reduce, prevent, or treat pain in patients. The depot is capable of releasing a specific percentage of clonidine over designated time periods, ensuring effective pain management. Another significant patent involves the combination of clonidine and bupivacaine for alleviating pain following surgery. This method provides an effective treatment option by administering these compounds at or near the target site.

Career Highlights

Throughout his career, McDonald has worked with prominent companies such as Warsaw Orthopedic, Inc. and Medtronic, Inc. His experience in these organizations has allowed him to refine his skills and contribute to advancements in medical technology.

Collaborations

McDonald has collaborated with notable individuals in his field, including Christopher M Hobot and Vanja Margareta King. These partnerships have fostered innovation and the development of effective pain management solutions.

Conclusion

Phillip Edward McDonald is a distinguished inventor whose work has significantly impacted post-operative pain management. His innovative patents and collaborations reflect his commitment to improving patient care through effective treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…